Biotech Investors

mendel partners logo

Mendel Partners' investor-network benefits from prequalified, funding-ready Biotech investment opportunities that match their unique fund criteria.

Before committing to supporting our Biotech clients, we utilise our vast network of start-up veterans and executives from the advanced therapies and rare diseases sectors. We assess their commercial potential before connecting them with relevant investors in our network.

Novel Cell & Gene Therapies and Orphan Drug approaches to treat rare diseases are changing the world of healthcare as we know it, and with a number of highly successful treatments and cures now on the market, the hunt for the most promising novel technologies to address high unmet medical needs has never been so great.

Mendel Partners
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.